Another slide worth noting is slide 14 of the presentation below.
Phylogica's peptide 1746 vaccine is highlighted together with XCR1 ligand that facilitates internalisation into cells. This FPP-peptide vaccine has the potential to synergize with existing immunotherapies. Peptides that can deliver cargoes to the cytoplasm is key. That's the goal. But I wonder whether there are other more potent peptides in the Phylogica's pipeline?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)